Hong-Zheng Bi

Recent advances in nanoscale combination delivery systems for colorectal cancer treatment.

Colorectal cancer (CRC) is the third most common cancer worldwide, and its clinical management remains limited by systemic toxicity and drug resistance. Combination regimens can improve therapeutic efficacy through synergistic mechanisms, yet they remain constrained by the divergent physicochemical properties of the pa...